FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to ophthalmology. A conjunctival cavity is first instilled with 0.05% picloxydine hydrochloride. That is followed by instillations of 0.1% riboflavin every 2 minutes for 20 minutes. Method includes transepithelial local accelerated cross-linking in erosion zone for 5 minutes at power density of 16.0 mW/cm2 three times every 2 days. Then 0.05% picloxydine hydrochloride and 5% dexpanthenol are instilled into conjunctival cavity 4 times a day until complete epithelisation.
EFFECT: invention provides faster regeneration of corneal epithelial defects.
1 cl, 2 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING RECURRENT EROSION OF CORNEAS OF VARIOUS ORIGINS | 2019 |
|
RU2716429C1 |
| METHOD OF TREATING RECURRENT CORNEAL EROSIONS | 2014 |
|
RU2575590C1 |
| METHOD OF SURGICAL TREATMENT OF CORNEAL ULCER OF VARIOUS ETIOLOGY | 2017 |
|
RU2652078C1 |
| METHOD OF TREATING COMPLICATIONS OF VIRAL AND BACTERIAL KERATOCONJUNCTIVITIS IN ANIMALS BY MEANS OF COLLAGEN CROSS-LINKING | 2018 |
|
RU2707792C1 |
| METHOD FOR CORNEAL COLLAGEN CROSSLINKING IN KERATECTASIAS OF VARIOUS GENESIS | 2021 |
|
RU2778968C1 |
| METHOD FOR ACCELERATED LOCAL CROSSLINKING OF CORNEA IN KERATECTASIA | 2023 |
|
RU2804716C1 |
| METHOD FOR SURGICAL TREATMENT OF CORNEAL DEFECTS IN LIMBAL CELL INSUFFICIENCY | 2022 |
|
RU2793525C1 |
| TREATMENT METHOD FOR CHRONIC CORNEA EROSIONS OF HERPETIC ETHIOLOGY | 2017 |
|
RU2653260C1 |
| METHOD FOR THE TREATMENT OF PERSISTENT EPITHELIAL CORNEAL DEFECT | 2022 |
|
RU2792394C1 |
| METHOD FOR THE TREATMENT OF ULCERATIVE LESIONS OF THE CORNEA AND GRAFT IN CHILDREN | 2021 |
|
RU2774036C1 |
